Senators Isakson, Perdue Co-sponsor Bipartisan Childhood Cancer Research Expansion

WASHINGTON, DC – U.S. Senators Johnny Isakson (R-GA) and David Perdue (R-GA) recently co-sponsored the bipartisan Childhood Cancer Survivorship, Treatment, Access, Research (STAR) Act, which would advance childhood cancer treatments through research and program development.

“It is extremely important that we increase research to develop new treatments and new therapies to cure the devastating effects of childhood cancer,” said Senator Isakson, who is a member of the Senate health committee and who also co-sponsored this legislation during the 114th Congress. “This critical legislation is a positive step forward to help find the right cures for our youngest patients.”

“As a voice for Georgia, it is imperative to speak up for our state’s youngest citizens,” said Senator Perdue. “No child should have to suffer from this horrible disease. This is a step in the right direction to expand childhood cancer research and improve the quality of life of those who survive childhood cancer.”


The Childhood Cancer STAR Act was unanimously approved by the House in December of 2016.

Specifically, the Childhood Cancer STAR Act would improve efforts to identify and track childhood cancer incidences, support research to improve the quality of life for childhood cancer survivors, and identify opportunities to expand the research of therapeutics necessary to treat the approximately 15,700 children diagnosed with cancer in the U.S. every year.

Senator Isakson and Senator Perdue are joined by U.S. Senators Jack Reed (D-RI), Roy Blunt (R-MO), Shelley Moore Capito (R-WV), Kirsten Gillibrand (D-NY), Marco Rubio (R-FL), Jeanne Shaheen (D-NH), and Chris Van Hollen (D-MD) in introducing this legislation.


Senator Perdue is the only Fortune 500 CEO in Congress and is serving his first term in the United States Senate, where he represents Georgia on the Armed Services, Banking, Budget, and Agriculture Committees.